LONG-TERM CLINICAL AND HEMODYNAMIC-RESULTS OF MOLSIDOMINE TREATMENT IN PATIENTS WITH REFRACTORY HEART-FAILURE

被引:10
作者
ACAR, J
KULAS, A
ESCUDIER, B
机构
关键词
D O I
10.1016/0002-8703(85)90682-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:685 / 687
页数:3
相关论文
共 8 条
[1]  
ESCUDIER B, 1982, 9TH WORLD C CARD MOS
[2]   ACUTE DOUBLE-BLIND TRIAL OF A NEW ANTI-ANGINAL DRUG - MOLSIDOMINE [J].
GUERCHICOFF, S ;
VAZQUEZ, A ;
KUNIK, H ;
DRAJER, S ;
DIAZ, F .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 13 (04) :247-250
[3]  
HASIMOTO K, 1972, ARZNEIMITTELFORSCH, V21, P1329
[4]  
JANSEN E, 1976, MED KLIN, V71, P2072
[5]   HEMODYNAMIC EFFECTS OF MOLSIDOMIN [J].
KARSCH, KR ;
RENTROP, KP ;
BLANKE, H ;
KREUZER, H .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 13 (04) :241-245
[6]   CARDIOVASCULAR ACTION OF MESOIONIC COMPOUNDS, 3-SUBSTITUTED SYDNONIMINES [J].
KIKUCHI, K ;
HIRATA, M ;
NAGAOKA, A ;
ARAMAKI, Y .
JAPANESE JOURNAL OF PHARMACOLOGY, 1970, 20 (01) :23-&
[7]  
KULAS A, 1984, ARCH MAL COEUR VAISS, V77, P92
[8]  
RUTHSCH W, 1979, MOLSIDOMIN NEVE ASPE, P84